The relationships between COMMD2 expression and the clinicopathological parameters of LIHC patients, including patient sex, patient age, cancer stage, tumor grade, nodal metastasis status and the TP53 mutation status, were analyzed using UALCAN database. This evidence concerns the gene TP53 and neoplasm.